The GCS team has been developing a press kit for our client Boehringer Ingelheim around the upcoming Rare Disease Day. Focusing on scleroderma, a condition classified as a ‘rare disease’ but which affects over 2.5 million people worldwide, the press kit will be utilized and rolled out across 16 markets on the 28 February.